Revvity Execs to Outline Strategy at Two Major Healthcare Conferences
Event summary
- Revvity will present at BofA Securities 2026 Health Care Conference on May 13, 2026, with SVP Steve Willoughby leading the discussion.
- CEO Prahlad Singh will present at Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026.
- Both presentations will include updates on company strategy and priorities.
- Live audio webcasts will be available on Revvity’s website, with replays accessible for at least 30 days post-event.
The big picture
Revvity’s participation in high-profile investor conferences underscores its push to reinforce its position in the healthcare innovation space. With $2.9 billion in 2025 revenue and a presence in over 160 countries, the company is likely to emphasize its workflow solutions from discovery to diagnosis. Investors will be watching for signals on how Revvity plans to navigate an increasingly competitive and technologically evolving industry.
What we're watching
- Strategic Clarity
- How Revvity’s updates will address its ability to maintain growth amid competitive pressures in the healthcare solutions sector.
- Leadership Insights
- Whether CEO Prahlad Singh’s presentation will signal shifts in long-term priorities or operational focus.
- Market Positioning
- The pace at which Revvity can differentiate itself in translational multi-omics and biomarker identification.
Related topics